Home / France / OSE Immunotherapeutics
OSE Immunotherapeutics
Short position disclosed on October 30, 2026. AMF register read on November 7, 2026.
Evolution of the disclosed total
May 28, 2021 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Citadel Securities (Europe) Limited | 0.77% | new | October 30, 2026 |
On the other side: the funds that hold OSE Immunotherapeutics Titelia
Get the moves on OSE Immunotherapeutics by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| October 30, 2026 | Citadel Securities (Europe) Limited | 0.77% | still open |
| October 27, 2026 | Citadel Securities (Europe) Limited | 0.59% | |
| October 22, 2026 | Citadel Securities (Europe) Limited | 0.63% | |
| October 21, 2026 | Citadel Securities (Europe) Limited | 0.58% | |
| October 20, 2026 | Citadel Securities (Europe) Limited | 0.60% | |
| October 15, 2026 | Citadel Securities (Europe) Limited | 0.41% | October 19, 2026 |
| October 13, 2026 | Citadel Securities (Europe) Limited | 0.51% | October 19, 2026 |
| October 7, 2024 | Qube Research & Technologies Limited | 0.47% | October 9, 2024 |
| October 3, 2024 | Qube Research & Technologies Limited | 0.55% | October 9, 2024 |
| October 2, 2024 | Qube Research & Technologies Limited | 0.62% | October 9, 2024 |
| September 13, 2024 | Qube Research & Technologies Limited | 0.73% | October 9, 2024 |
| September 12, 2024 | Qube Research & Technologies Limited | 0.64% | October 9, 2024 |
| September 11, 2024 | Qube Research & Technologies Limited | 0.54% | October 9, 2024 |
| June 2, 2021 | Voleon Capital Management LP | 0.49% | June 4, 2021 |
| May 28, 2021 | Voleon Capital Management LP | 0.50% | June 4, 2021 |
Download 15 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Valeo 12.85% of the capital sold short
- Renault 11.51% of the capital sold short
- Viridien 10.26% of the capital sold short
- Ubisoft Entertainment 9.76% of the capital sold short
- FDJ United 6.73% of the capital sold short
- Alstom 5.94% of the capital sold short
- Abivax 5.69% of the capital sold short
- Teleperformance 5.45% of the capital sold short
- Gaztransport et Technigaz 4.88% of the capital sold short
- Atos Group 4.41% of the capital sold short
- Forvia 4.38% of the capital sold short
- Nexity 4.16% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, OSE Immunotherapeutics, source AMF, data as at October 30, 2026, https://www.quivad.com/action/ose-immunotherapeutics
Embed the chart
<iframe src="https://www.quivad.com/embed/action/ose-immunotherapeutics" width="600" height="280" title="OSE Immunotherapeutics" loading="lazy" style="border:0"></iframe>
Badge
<a href="https://www.quivad.com/action/ose-immunotherapeutics"><img src="https://www.quivad.com/action/ose-immunotherapeutics/badge.svg" alt="QuiVad, OSE Immunotherapeutics"></a>